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• In clinical trials or cohort studies, measurements are repeatedly measured over time (e.g. blood pressure), which we call longitudinal data
• In addition, the time to one or more clinical endpoints (e.g. death) is recorded, which we call time-to-event data
• Historically, these data have been analysed separately
Introduction
https://www.liverpool.ac.uk/translational-medicine/departmentsandgroups/joine-r/about/
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available from CRAN
 Left: two biomarkers measured 
from blood tests repeatedly over 
time for 312 patients with primary 
biliary cirrhosis randomised to a 
new drug
 Right: cumulative incidence 
curves for 2 competing events
Time-to-event outcomesExample
Correlated?
Standard model: (generalised) linear mixed 
effects regression model
Potential problems:
• Sickest patients more likely to drop out of 
study
• We call this informative missingness
Interest = longitudinal data
Standard model: Cox proportional hazards 
regression model
Potential problems:
• Biomarkers measured with error
• Time-varying covariates modelled as 
constant between measurement times
Interest = time-to-event data
Ignoring the correlation between 
information from the same 
patient can result in incorrect 
conclusions about the new 
treatments and predictions of 
clinical endpoints
Why does it matter?
Combined analysis of the outcomes (joint modelling) using some unknown variables to capture the 
association between the two types of outcome
Proposed solution
• Joint modelling methodology has been 
predominantly focused on univariate 
(single longitudinal and event outcome) 
data
• In practice, multiple longitudinal 
outcomes and event times will be 
recorded (multivariate data)
• Multivariate data greatly increases the 
complexity of model estimation:
• Computational time grows with 
increasing number of outcomes
• Longitudinal outcomes take different 
types (e.g. continuous, binary, 
ordinal)
Extension to multivariate data (JoineR-M)
• joineR is a freely available user-friendly 
software package, currently fit joint 
models for univariate data
• joineR will be expanded over the next 
2-years to:
• Include multivariate longitudinal 
outcomes
• Model competing risks outcomes
• Provide model diagnostics to allow 
inspection of model fit 
• Training workshops for biomedical 
researchers to inform the joint modelling 
methods and software
Software development
Longitudinal outcomes
• More efficient estimates of 
treatment effects = reduced 
number of patients required for 
studies and increased power
• Less biased estimates of the 
treatment effects = closer to ‘truth’
• More accurate predictions of 
events = better medical decision-
making
Benefits of joint modelling
